Comments on 'Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome' by Zeger et al., pp. 39-47, this issue.
Leonie A
LA
Menke
Theo C J
TC
Sas
Jan M
JM
Wit
D000293:Adolescent; D041923:Adolescent Development / Q000187:drug effects*; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001827:Body Height / Q000187:drug effects*; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D019382:Human Growth Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010074:Oxandrolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010352:Patient Dropouts; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014424:Turner Syndrome / Q000188:drug therapy*; D014770:Virilism / Q000139:chemically induced / Q000517:prevention & control
D000728:Androgens; D019382:Human Growth Hormone; D010074:Oxandrolone